Esmolol Hydrochloride Injection
NDC Package 55150-421-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Esmolol Hydrochloride (esmolol hydrochloride in sodium chloride) injection is esmolol hydrochloride injection is available in a single dose vial. This formulation utilizes a injection delivery system. Marketed by Eugia Us Llc, this product is identified by NDC 55150-421 and is authorized under FDA application ANDA216244.

Identification & Billing

NDC Package Code
55150-421-10
Package Description
10 POUCH in 1 CARTON / 1 BAG in 1 POUCH (55150-421-01) / 100 mL in 1 BAG
Product Code
55150-421
11-Digit Billing Format
55150042110
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Esmolol Hydrochloride
Non-Proprietary Name
Esmolol Hydrochloride In Sodium Chloride
Substance Name
Esmolol Hydrochloride
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
ESMOLOL HYDROCHLORIDE 20 mg/mL
Pharmacologic Class
Usage Information
Esmolol hydrochloride injection is available in a single dose vial. Esmolol hydrochloride injection is not compatible with Sodium Bicarbonate (5%) solution (limited stability) or furosemide (precipitation). Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.Single Dose VialThe Single Dose Vial may be used to administer a loading dosage by hand-held syringe while the maintenance infusion is being prepared.Compatibility with Commonly Used Intravenous FluidsEsmolol hydrochloride injection was tested for compatibility with ten commonly used intravenous fluids at a final concentration of 10 mg Esmolol Hydrochloride per mL. Esmolol hydrochloride injection was found to be compatible with the following solutions and was stable for at least 24 hours at controlled room temperature or under refrigeration:Dextrose (5%) Injection, USPDextrose (5%) in Lactated Ringer’s InjectionDextrose (5%) in Ringer’s InjectionDextrose (5%) and Sodium Chloride (0.45%) Injection, USPDextrose (5%) and Sodium Chloride (0.9%) Injection, USPLactated Ringer’s Injection, USPPotassium Chloride (40 mEq/liter) in Dextrose (5%) Injection, USPSodium Chloride (0.45%) Injection, USPSodium Chloride (0.9%) Injection, USP

Regulatory & Marketing

Labeler Name
Eugia Us Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA216244
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-21-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J1805
Source: PDAC
INJECTION, ESMOLOL HYDROCHLORIDE, 10 MG
HCPCS Dosage 10 MG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55150-421-10 identifies a specific commercial package of 10 pouch in 1 carton / 1 bag in 1 pouch (55150-421-01) / 100 ml in 1 bag of Esmolol Hydrochloride, a human prescription drug labeled by Eugia Us Llc. This injection is formulated for intravenous use and contains esmolol hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eugia Us Llc on March 21, 2022. The current certification is valid through December 31, 2026.

How is this Eugia Us Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55150042110. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55150-421-10
11-Digit CMS (5-4-2)
55150-0421-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.